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Department of Medicine , Welsh National School of Medicine, Cardiff, Wales 
Epidermal dimensions, replication, and anabolic activity have been studied before and 
after treatment in 10 patients with thyrotoxicosis and 7 patients with hypothyroidism. 
Following treatment of thyrotoxicosis there was a significant decrease in epidermal thick-
ness, and also in cell replication as measured by an autoradiographic labeling index 
technique. The rates of anabolic activity in the epidermis, as estimated by measuring the 
rates of incorporation of tritiated precursor compounds, were significantly reduced after 
treatment in the thyrotoxic group. There were increases in these same measurements in the 
hypothyroid group following treatment although their magnitude was not as great as that 
seen after treatment of thyrotoxicosis. There was a significant positive correlation between 
serum triiodothyronine and epidermal thickness, labeling index and proline incorporation, 
but no correlation could be detected between serum thyroxine iodine and any of the 
epidermal measurements. These findings indicate that the epidermis changes in structure 
and activity in thyroid disease, and that the changes are rapidly reversible. Furthermore, 
the correlations we have found suggest that the receptors for thyroid hormone in human 
skin are specific for triiodothyronine. 
Changes occur in the epidermis in patients with 
thyroid disease [1]. Epidermal thickness and rete 
pattern are reduced in hypothyroidism and the 
rates of epidermal cell division and anF,bolic activ-
ity in the epidermis are increased in thyrotoxi-
cosis. 
The aim of this study has been to determine 
whether the abnormalities observed in thyroid dis-
ease return to normal following treatment of the 
thyroid disorder and to discover whether a correla-
tion exists between any of the changes observed 
and parameters of thyroid gland activity. 
PATIENTS AND METHODS 
Ten patients with thyrotoxicosis (3 male, 7 female; 
age range 36 to 79 years; mean, 56 years) and 7 patents 
with hypothyroidism (6 female, 1 male; age range 54 to 
80 years; mean, 65 years) were studied and compared to 
a control group of25 normal adults (17 female, 8 male; 
age range 18 to 77 years; mean, 51 years). A diagnosis of 
Lhyroid disease was made by clinical examination a nd 
conftrmed by estimation of serum thyroxine iodine (T. l, 
a free thyroxine index, and serum triiodothyronine 
(T3J. The patients with hypothyroidism received L-thy-
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Abbreviations: 
BIG: length of the basal layer to length of the 
granular cell layer 
L. 1.: labeling index 
MECN: mean epidermal cell number 
MKH: mean keratinocyte height 
T3 : serum triiodothyronine 
T.: serum thyroxine iodine 
roxine as replacement therapy and all the patients with 
thyrotoxicosis were treated with carbimazole. The mea-
surements on the epidermis were carried out before and 
aft.er treatment (24-32 weeks duration). 
Epidermal Dlmension 
Skin biopsies were taken from the deltoid area in all 
patients studied. The tissue was fixed in 10% formalin 
and dehydrated, embedded in paraffin before section-
ing, and stained with hematoxylin and eosin. The num-
ber of cell layers forming the viable epidermal compart-
ment was determined by direct counting of nuclei from 
the basal layer to the top of the granular cell layer 
along an axis perpendicular to the surface at 30 random 
points and expressed as the mean epidermal cell num-
ber CMECN). 
The rete pattern of the epidermis was measured by 
calculating the ratio of the length of the basal layer to 
the length of the granular cell layer (B/G ratio) using a 
microscope drawing tube-projection technique. The size 
of keratinocytes was expressed as the mean keratino-
cyte height (MKHJ. This was calculated by dividing the 
actual thickness of the viable epidermis in microns by 
the MECN . The mean epidermal thickness was deter-
mined by measurement at 30 random points using a 
calibrated eyepiece graticule. 
Epidermal Growth 
The replicative activity of the epidermis was studied 
in two ways: 
In uiuo method. This was performed in 16 patients 
over the age of 40. Biopsy specimens were taken from 
the deltoid area 1 hr after intracutaneous injection of 10 
~J.Ci of tritiated thymidine, (sp act 18 Ci/mmole) in 0.1 
mJ of normal saline. Autoradiographs were prepared 
using a dipping method [2]. The number of basal and 
supra basal cells that became labeled was expressed as a 
percentage of the total number of basal cells (labeling 
index, L.l.). 
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TABLE . Epidermal dimensions , labeling indices, and anabolic actiuity in the control group and the thyrotoxic and 
hypothyroid groups before and after treatment (mean ± SE of mean) and statistical signifiCance of the differences 
betu•een the measurements before and after treatment in the two disease groups studied 
Thyrotoxicosis Hypothyrodism 
Control Post-treat- Signifi- Pretreat- Post-treat- Signifi-Pretreatment 
menl cance ment ment cance 
BIG 1.12 = 0.02 1.09 :t 0.03 1.02 :t 0.03 n.s. 1.04 :t 0.02 1.05 :t 0.04 n .s. 
MECN 4.52 = 0.19 4.58 :t 0.2 3.84 :t 0.2 p < 0.005 3.0 = 0.1 4.0 ± 0.3 p < 0.01 
Epidermal thickness (I-' l 50.43 = 3.1 54.34 :!: 3.2 46.8 :t 2.9 p < 0.05 38.0 = 3.0 41.5 :t 3.3 n.s. 
MKH (I-'l 11.4 :t 0.4 11.8 :!: 0.4 12.1 = 0.4 n.s. 12.4 :!: 0.8 10.4 :!: 0.3 p < 0.05 
L.l.% 5.1 :!: 0.4 8.84 :t 0.7 4.7 = 0.2 p < 0.001 4.5::: 0.4 4.8 :!: 0.4 n.s. 
Thymidine incorporation 15.1 :!: 2.3 21.0 = 3.1 37.9:!: 4.9 p < 0.005 14.9 ± 5.1 27.4 :!: 4.1 p < 0.05 
Proline incorporation 59.7 :!: 7.4 142.2 :!: 23 .5 71.4 :!: 8.3 p < 0.01 37.1 :!: 12.9 67.0 :!: 16.1 n.s. 
Histidine incorporation 22.1 :!: 2.5 35.9 :t 5.6 30.8 :t 4. 7 n.s. 20.1 :t 7.5 28.1 :!: 5.3 n.s. 
n.s. = Not significant. 
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FIG. 1. Correlation between serum triiodothyronine and (A ) MECN and epidermal thickness, and (B ) label ing 
index and proline incorporation. Normal range for serum triiodothyronine 0.65-2.0 ng/ml. 
In uitro method. The rates of incorporation of triti-
ated thymidine into skin sheets were estimated (see 
below). 
A nabolic Actiuity 
Measurements were made of the rates of incorpora-
tion of tr itiated proline (sp act 18 Ci/ mmole) and triti-
ated histidine (sp act 44 Ci/mmole) into rectangular 
fragments of skin approximately 50 mm2 in area ob-
tained from the lateral aspect of the thigh with a Cas-
troviejo keratotome set at 0.4 mm. The skin fragments 
were maintained in vitro for 4 br in the presence of the 
tritiated precursor compound. The technique is based 
on that of Marks , Fukui, and Halprin [31 and is de-
scribed in more detail by Holt and Marks [4]. 
Tritiated thymidine (sp act 2 Ci/mmole) was also 
used in order to assess replicative activity (see below). 
The results were expressed as corrected counts per mini 
mm2 tissue/hr incubation (thymidine, proline, or histi-
dine units). 
RESULTS 
The results are shown in the Table. The mean 
MECN and epidermal thickness were reduced by 
May1977 
16% (p < 0.005) and 14% (p < 0.05), respectively, 
following treatment of thyrotoxicosis, and the 
MECN was increased by 25% (p < 0.01) following 
treatment of hypothyroidism. The labeling index 
in the thyrotoxic group fell by 47% (p < 0.001) after 
treatment. Proline incorporation fell by 50% (p < 
0.01) in the thyrotoxic group after treatment and 
increased by 45% after treatment of hypothyroid-
ism. Histidine incorporation showed a similar 
trend to proline incorporation. The values of pre-
cursor incorporation were not significantly altered 
when corrected for epidermal thickness. There 
was a significant positive correlation between T3 
and MECN (r = 0.65), and epidermal thickness 
(r = 0. 70) (Fig. lA) and labeling index (r = 0.67) 
and proline incorporation (r = 0.77) (Fig. lB). 
There was no correlation between T4 and any of 
the epidermal measurements. 
DISCUSSION 
We have shown [1] that there are considerable 
differences between epidermal dimensions, repli-
cation, and anabolic activity in patients with thy-
rotoxicosis and in patients with hypothyroidism. 
The observed changes in these measurements now 
seen following treatment of the thyroid disorder 
reinforce the suggestion that the epidermis is in-
fluenced by the peripheral action of thyroid hor-
mones and indicate that the changes take place in 
a relatively short period of time. 
Our results indicate that epidermal cell prolifer-
ation is profoundly affected in thyroid disease. The 
use of labeling indices after exposure to tritiated 
thymidine is commonly held to reflect the prolifer-
ative status of the epidermis. We realize that this 
is not strictly correct as this measurement also 
will record changes in the length of the DNA 
synthesis period L5]. Despite these limitations, la-
beling indices still provide a useful measure of 
epidermopoiesis, as in those skin disorders in 
which the length of S phase has been measured it 
has not differed dramatically from normal. Fur-
thermore, L.I. correlates well with other measure-
ments that reflect the rate of epidermal cell divi-
sion. 
Limited nuclear binding sites for Ta have been 
demonstrated in the rat, their concentration vary-
ing widely in different tissues [6]. The strong cor-
relation seen between the epidermal measure-
ments and T3 is in contrast to the poor correlation 
with T4 , and suggests that the receptors for thy-
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roid hormone in human skin are specific for T3. 
Tata and Widnell [7] have indicated that the effect 
of T:1 on cells is mediated by the formation of new 
RNA which eventuates in new protein synthesis. 
The tritiated precursors proline and histidine are 
incorporated into epidermal proteins which are 
continuously formed in maturing epidermis and 
then destroyed or incorporated into proteins that 
are stable and appear in surface scale. Their incor-
poration, therefore, reflects epidermal anabolism. 
The differences in amino acid incorporation seen 
before and after treatment of the underlying thy-
roid disease, together with the significant correla-
tion between proline incorporation and serum tri-
iodothyronine levels, indicate further that there is 
a receptor for triiodothyronine in human epider-
mal cells which represents the point of initiation of 
reactions expressed by the hormone. 
The results of the in vitro tests of thymidine 
incorporation do not parallel the trend obtained by 
autoradiography from the in vivo studies. The rea-
son for this is not clear. Probably several factors 
combine to produce this apparent anomaly. 
Among these must be included the fact that thymi-
dine incorporation expressed as a function of area 
does not take into consideration the population 
growth fraction alone but will include the synthe-
sis of nonreplicative DNA and even include DNA 
repair. Another contributory factor is the fact that 
thymidine diffuses less readily through intact tis-
sue in vitro compared to its diffusion in vivo. 
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